Medico Intercontinental Ltd
Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]
- Market Cap ₹ 31.5 Cr.
- Current Price ₹ 31.5
- High / Low ₹ 44.9 / 26.0
- Stock P/E
- Book Value ₹ 47.8
- Dividend Yield 0.00 %
- ROCE 13.8 %
- ROE 10.8 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.66 times its book value
- Promoter holding has increased by 1.98% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.22% over past five years.
- Company has a low return on equity of 10.8% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.1.31 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 9.95 | 81.93 | 69.74 | 74.26 | 76.23 | 71.33 | 96.01 | 82.76 | |
| 0.34 | 9.29 | 77.57 | 64.97 | 69.25 | 70.97 | 65.50 | 87.58 | 79.43 | |
| Operating Profit | -0.34 | 0.66 | 4.36 | 4.77 | 5.01 | 5.26 | 5.83 | 8.43 | 3.33 |
| OPM % | 6.63% | 5.32% | 6.84% | 6.75% | 6.90% | 8.17% | 8.78% | 4.02% | |
| 0.39 | 0.36 | 0.05 | 0.18 | 0.31 | 0.51 | 0.40 | 0.35 | 1.31 | |
| Interest | 0.00 | 0.01 | 1.10 | 1.28 | 0.88 | 0.62 | 0.50 | 1.00 | 6.62 |
| Depreciation | 0.00 | 0.00 | 0.10 | 0.14 | 0.21 | 0.20 | 0.29 | 0.81 | 4.28 |
| Profit before tax | 0.05 | 1.01 | 3.21 | 3.53 | 4.23 | 4.95 | 5.44 | 6.97 | -6.26 |
| Tax % | 40.00% | 26.73% | 26.17% | 26.91% | 26.71% | 27.07% | 27.39% | 27.55% | |
| 0.03 | 0.74 | 2.36 | 2.58 | 3.10 | 3.61 | 3.95 | 5.06 | -7.49 | |
| EPS in Rs | 0.09 | 2.28 | 7.26 | 7.94 | 9.54 | 3.61 | 3.95 | 5.06 | -1.38 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.77% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 9% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 18% |
| TTM: | -128% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | -27% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 11% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserves | 0.02 | 0.75 | 3.11 | 6.29 | 9.39 | 31.19 | 35.03 | 38.65 | 37.76 |
| 0.02 | 0.11 | 13.66 | 9.31 | 8.73 | 4.72 | 4.86 | 16.92 | 65.54 | |
| 0.62 | 5.02 | 16.02 | 11.80 | 10.55 | 12.97 | 6.16 | 10.20 | 3.25 | |
| Total Liabilities | 3.91 | 9.13 | 36.04 | 30.65 | 31.92 | 58.88 | 56.05 | 75.77 | 116.55 |
| 0.01 | 0.00 | 1.68 | 2.35 | 2.36 | 2.57 | 3.52 | 8.69 | 52.71 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.16 | 0.01 | 0.02 | 0.02 | 0.02 | 2.44 |
| 3.90 | 9.13 | 34.36 | 28.14 | 29.55 | 56.29 | 52.51 | 67.06 | 61.40 | |
| Total Assets | 3.91 | 9.13 | 36.04 | 30.65 | 31.92 | 58.88 | 56.05 | 75.77 | 116.55 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.93 | -13.82 | 5.82 | 3.85 | -10.10 | 5.58 | -7.11 | |
| 0.00 | 0.00 | 0.00 | -0.94 | -1.30 | -5.38 | -8.54 | -2.19 | |
| 0.00 | 0.09 | 13.42 | -5.14 | -1.20 | 20.41 | -0.46 | 8.63 | |
| Net Cash Flow | 0.02 | 1.02 | -0.40 | -0.26 | 1.35 | 4.92 | -3.42 | -0.68 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 237.34 | 101.44 | 94.10 | 84.25 | 157.29 | 118.77 | 124.89 | |
| Inventory Days | 0.00 | 25.84 | 45.69 | 57.71 | 47.27 | 52.03 | 69.45 | 45.20 |
| Days Payable | 201.37 | 73.54 | 66.83 | 50.21 | 66.73 | 29.93 | 36.54 | |
| Cash Conversion Cycle | 61.81 | 73.59 | 84.98 | 81.31 | 142.58 | 158.28 | 133.54 | |
| Working Capital Days | 78.14 | 74.22 | 68.40 | 65.62 | 131.96 | 133.71 | 156.36 | |
| ROCE % | 27.57% | 35.72% | 24.75% | 25.41% | 16.56% | 12.40% | 13.82% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count ・Standalone data |
|
|||||||||
| Number of Wholly Owned Subsidiaries Count ・Standalone data |
||||||||||
| Debtors Turnover Ratio Times ・Standalone data |
||||||||||
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb
-
Results - For The Quarter And Nine Months Ended December 31, 2025.
14 Feb - Q3 and nine-month unaudited results to 31 Dec 2025: standalone revenue Rs1,354.44L, PAT Rs61.15L.
-
Board Meeting Outcome for Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
14 Feb - Board approved unaudited standalone and consolidated results to Dec 31, 2025; Q3 revenue Rs1,354.44 lakh; reviewed Feb 14, 2026.
-
Board Meeting Intimation for Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (LODR) Regulations, 2015.
4 Feb - Board meeting on 14 Feb 2026 to approve unaudited Q3 and nine-month results ended Dec 31, 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Jan
Business Overview:[1][2]
MIL (Formerly M/S. Intercontinental Leasing
& Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital,
etc.